Concord Biotech Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23

Profit before tax

495.88

409.19

320.05

Net cashflow-operating activity

244.52

265.47

246.00

Net cash used in investing activity

-159.99

-154.61

-157.95

Netcash used in fin. activity

-98.77

-99.21

-85.22

Net inc/dec in cash and equivlnt

-14.24

11.64

2.83

Cash and equivalnt begin of year

15.14

3.50

0.67

Cash and equivalnt end of year

0.90

15.14

3.50